UPDATE: Citi Upgrades Mindray to Buy
According to Citi, Mindray (NYSE: MR) is upgraded to Buy.
Citi said that it upgrades Mindray based on Citi's first Chinese hospital survey that highlights the country's medtech growth opportunities. “Upgrade to Buy, TP US$31 (was US$29).”
Mindray closed on Friday at 26.36.







